# Undiagnosed placenta accreta spectrum complicated by massive haemorrhage during mid-trimester medical termination of pregnancy: a case report

**Authors:** Natalie Drever, Sunthra Shanmuga Lingam, Joanna Arnold

PMC · DOI: 10.1016/j.crwh.2026.e00790 · Case Reports in Women's Health · 2026-02-17

## TL;DR

A woman with a history of multiple caesareans experienced life-threatening bleeding during a mid-trimester abortion due to an undiagnosed placenta accreta condition.

## Contribution

This case highlights the diagnostic challenges and severe risks of placenta accreta during mid-trimester abortions, especially in women with prior caesareans.

## Key findings

- Mid-trimester imaging may fail to detect placenta accreta despite targeted ultrasound.
- Unrecognized placenta accreta during abortion can lead to catastrophic maternal hemorrhage.
- Women with prior caesareans and placenta previa are at higher risk for accreta-related complications.

## Abstract

Placenta accreta spectrum (PAS) is a well-recognised cause of severe obstetric haemorrhage in late pregnancy but is rarely encountered during abortion, particularly in the mid-trimester. Diagnosis in this setting is challenging, and unrecognised abnormal placentation may result in catastrophic maternal morbidity. We report the case of a 28-year-old multiparous woman with three prior caesareans who presented at 17 weeks of gestation with preterm prelabour rupture of membranes and placenta previa. Targeted mid-trimester ultrasound reviewed by a maternal–fetal medicine subspecialist demonstrated no sonographic features suggestive of PAS. Following counselling, medical termination of pregnancy was initiated using mifepristone and misoprostol. Uncontrolled bleeding led to timely transfer to the operating theatre for hysterotomy and management of haemorrhage. The procedure was complicated by sudden massive haemorrhage, haemodynamic collapse, and intraoperative cardiac arrest. Despite uterine evacuation and resuscitative measures, uncontrolled bleeding necessitated an emergency subtotal hysterectomy, complicated by dense vesicouterine adhesions and bladder injury. The patient survived following massive transfusion, intensive care admission, and multidisciplinary management. This case highlights the limitations of mid-trimester imaging in reliably excluding clinically significant PAS. It also underscores the potential for abrupt, life-threatening haemorrhage during medical termination of pregnancy in women with multiple previous caesarean deliveries. As caesarean rates rise, clearer guidance is needed regarding risk stratification, imaging pathways, and procedural planning for mid-trimester abortion to minimise maternal morbidity.

•Placenta accreta encountered during abortion may lead to severe haemorrhage.•Mid-trimester diagnosis of accreta remains challenging despite targeted ultrasound.•Placenta praevia with prior caesarean should raise suspicion of accreta.•Outcomes appear worse when placenta accreta is unrecognised prior to abortion.•Limited evidence guides abortion method after multiple prior caesareans.

Placenta accreta encountered during abortion may lead to severe haemorrhage.

Mid-trimester diagnosis of accreta remains challenging despite targeted ultrasound.

Placenta praevia with prior caesarean should raise suspicion of accreta.

Outcomes appear worse when placenta accreta is unrecognised prior to abortion.

Limited evidence guides abortion method after multiple prior caesareans.

## Linked entities

- **Chemicals:** mifepristone (PubChem CID 4196), misoprostol (PubChem CID 5282381)
- **Diseases:** placenta previa (MONDO:0005918)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** tamponade (MESH:D002305), MToP (MESH:D011254), chorioamnionitis (MESH:D002821), myalgia (MESH:D063806), pregnancy loss (MESH:D000022), leukocytosis (MESH:D007964), prelabour rupture of membranes (MESH:D005322), abortion (MESH:D000026), abnormal placentation (MESH:D010922), intrauterine infection (MESH:D007239), adhesions (MESH:D000267), vaginal bleeding (MESH:D014592), haemodynamic collapse (MESH:D001261), bladder injury (MESH:D001745), PPROM (MESH:C563032), hypotension (MESH:D007022), obstructed labour (MESH:D000402), caesarean scar (MESH:D002921), bleeding (MESH:D006470), PAS (MESH:D010921), febrile (MESH:D000071072), blood loss (MESH:D016063), cardiac arrest (MESH:D006323), placenta previa (MESH:D010923), uterine rupture (MESH:D014597)
- **Chemicals:** misoprostol (MESH:D016595), gemeprost (MESH:C021182), mifepristone (MESH:D015735)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12934206/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12934206/full.md

---
Source: https://tomesphere.com/paper/PMC12934206